Double-blind placebo-controlled study of terazosin in patients with chronic abacterial prostatitis


Citar

Texto integral

Resumo

A double-blind placebo-controlled trial of teraosin efficacy (Kornam, Lek, Slovenia) was made in 51 patients with chronic abacterial prostatitis/chronic pelvic pain syndrome (CAP/CPPS) of category Ilia according to NIH. All the patients were given a 2-week induction course of placebo followed by teraosin treatment (5 mg/day, n = 29) or placebo (n = 22) for 8 weeks. The participants of the study were followed up for 12 months. Pretreatment differences between the groups by NIH-CPSI system, symptoms frequency scale, leukocyte count of the prostate and uroflowmetry were insignificant. Teraosin and placebo patients showed a noticeable improvement (39.7 and 9.9% by symptoms frequency scale, respectively; by 36.4 and 6.6% by the linear scale, respectively). The drug reduced pain and dysuria, improved quality of life considerably (by 36.2%). Maximal urine flow accelerated by 22.96 and 10.01% in teraosin and placebo groups, respectively. Leukocyte count fell two-fold in the study group and lowered insignificantly in the placebo group. The recurrence-free interval was 25 and 9 weeks, respectively. Thus, teraosin monotherapy improves quality of life in CAP/CPPS patients, significantly relieves symptoms and prolongs recurrence-free interval vs placebo.

Sobre autores

A Sivkov

V Oschepkov

A Egorov

Bibliografia

  1. Peters Т. J., Donovan J. L., Kay H. E. et al. The international Continence Society "Benign Prostatic Hyperplasia' Study: the bothersomeness of urinary symptoms. J. Urol. (Baltimore). 1997; 157: 885-889.
  2. Scarpa R. M. Lower urinary tract symptoms (LUTS): what are the implications for the patients? Eur. Urol. 2001; 40 (suppl. 4): 12-20.
  3. Price D. Potential mechanism of action of superselective a-1adrenoreceptor antagonist. Eur. Urol. 2001; 40 (suppl. 4): 5- 11.
  4. Hampel C., Dolber P. C., Smith M. P. et al. Modulation of bladder alphal-adrenergic receptor subtype expression by bladder outlet obstruction. J. Urol. (Baltimore). 2002; 167: 1513-1521.
  5. Kaplan S. A., Ikeguchi E. F., Santarosa R. P. et al. Etiology of voiding dysfunction in men less than 50 yars of age. Urology. 1996; 47: 836-839.
  6. Сивков А. В., Егоров А. А., Ромих В. В. Псевдодиссинергия и синдром хронической тазовой боли у больных хроническим абактериальным простатитом. Существует ли взаимосвязь? Материалы Пленума правления РОУ, Саратов 8- 10 июня 2004. М.: 2004. 260-261.
  7. Mehik A., Hellstrom P., Lukkarinen О. et al. Increased intraprostatic pressure in patients with chronic prostatitis. Urol. Res. 1999; 27 (4): 227-229.
  8. Kirby R. S., Lowe D., Bultitude M. L., Shuttleworth К. Е. Intraprostatic urinary reflux: an etiological factor in abacterial prostatitis. Br. J. Urol. 1982; 54: 729-731.
  9. Litwin M. S., McNaughton-Collins M., Fowler F. J. J. et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J. Urol. (Baltimore). 1999; 162: 369-375.
  10. Osborn D. E., George N. J. R., Rao P. N. et al. Prostatodynia: physiological characteristics and rationale management with muscle relaxants. Br. J. Urol. 1987; 53: 621-623.
  11. Weiss S. G, Moon T. D. a-Blocker therapy. In: Nickel J. С ed. Textbook of prostatitis. Oxford; 1999. 319-327.
  12. Nickel J. C., Narayan P., McKay J. et al. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial, J. Urol. (Baltimore). 2004; 171: 1594-1597.
  13. Ткачук В. Н., Аль-Шукри С. X., Кузнецова М. И., Торосян О. Р. Тамсулозин в лечении больных хроническим простатитом. Урология. 2000; 5: 18-20.
  14. Сивков А. В., Ощепков В. И., Егоров А. А. Применение а,адреноблокаторов у больных хроническим простатитом. Consilium Medicum. 2002; 4: 385-390.
  15. Лопаткин Н. А., Аполихин О. И., Сивков А. В. и др. Результаты монотерапии теразозином пациентов хроническим неинфекционным простатитом. Урология. 2002; 5 (приложение): 37-52.
  16. Nickel J. С., Sorensen R. Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires. / J. Urol. (Baltimore). 1996; 155: 1950-1955.
  17. Ощепков В. Н., Дарий Е. В., Сивков А. В. Стандартизированная оценка симптомов хронического простатита. В кн.: Вопросы андрологии в урологии. М.: НИИ урологии МЗ РФ. 2000; 11: 100-109.
  18. True L. D., Berger R. E., Rothman I. et al. Prostate histopathology and the chronic prostatitis / chronic pelvic pain syndrome: a prospective biopsy study. J. Urol. (Baltimore). 1999; 34 (6): 457-466.
  19. Svihra J., Elias В., Javorka K. Jr., Kliment J. Diagnosis and treatment of functional disorders of the lower urinary tract in younger men. Bratisl. Lek. Listy. 2000; 101 (5): 302-305.
  20. Liao L. M., Shi B. Y., Liang С. Q. Ambulatory urodynamic monitoring of external urethral sphincter behavior in chronic prostatitis patients. Asian J. Androl. 1999; 1 (4): 215-217.
  21. Hetrick D., Ciol M., Turner J. et al. Pelvic muscle evaluation in men with chronic pelvic pain and controls. AUA 2002. Abstr. on CD-Rom.
  22. Сивков А. В., Ощепков В. Н., Егоров А. А. Терапия хронического абактериального простатита. В кн.: Тезисы Пленума правления Российского общества урологов, Саратов 8-10 июня 2004. Саратов; 2004. 216-230.
  23. Neal D. E., Moon Т. D. Use of terasosin in prostatodynia and validation of symptom score questionnaire. Urology. 1994; 43: 460-465.
  24. Cheah P. Y., Liong M. E., Yuen K. H. et al. Long-terra effectiveness of terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). AUA 2003. Abstr. on CD-Rom.
  25. Gul O., Eroglu M., Ozok U. Use of terazosine in patients with chronic pelvic pain syndrome evaluation bv prostatitis svmptom score index. Int. Urol. Nephrol. 2001; 32'(3): 433-436.
  26. Лопаткин Н. А., Сивков А. В., Аполихин О. И. и др. Хронический простатит. CD-ROM, НИИ урологии МЗ РФ; 20О4.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies